Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05011760
EARLY_PHASE1

[C-11]NPA PET-amphetamine in Cocaine Use Disorders

Sponsor: Rajesh Narendran

View on ClinicalTrials.gov

Summary

This study uses \[11C\]NPA positron emission tomography (PET) and a d-amphetamine challenge to image amphetamine induced dopamine release in the striatum in subjects with cocaine use disorders (CUD). Amphetamine-induced dopamine release data from this study will be correlated with \[11C\]NOP-1A VT measured at baseline in the midbrain. \[11C\]NOP-1A PET data will be used from aim 1 (see, Study Record: Imaging CRF X NOP interactions in Cocaine Use Disorders)

Official title: [C-11]NPA PET-amphetamine in Cocaine Use Disorders (Aim 2)

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2021-01-31

Completion Date

2028-09-01

Last Updated

2025-06-05

Healthy Volunteers

No

Interventions

RADIATION

Baseline [C-11]NPA PET Scan

Radiotracer

DRUG

d-amphetamine

Oral, 0.5 mg/Kg

RADIATION

Post-amphetamine [C-11]NPA PET Scan

Radiotracer

Locations (1)

University of PIttsburgh

Pittsburgh, Pennsylvania, United States